Abbott Laboratories (ABT)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	13,402,000	5,767,000	5,557,000	5,630,000	5,723,000	5,162,000	5,161,000	5,804,000	6,933,000	7,889,000	8,554,000	7,725,000	7,071,000	7,244,000	6,376,000	5,724,000	4,495,000	3,382,000	3,110,000	3,579,000
Total assets	US$ in thousands	81,414,000	74,356,000	73,017,000	72,467,000	73,214,000	72,090,000	73,354,000	73,794,000	74,438,000	72,801,000	74,202,000	74,007,000	75,196,000	73,795,000	73,269,000	72,785,000	72,548,000	69,043,000	68,793,000	66,712,000
ROA		16.46%	7.76%	7.61%	7.77%	7.82%	7.16%	7.04%	7.87%	9.31%	10.84%	11.53%	10.44%	9.40%	9.82%	8.70%	7.86%	6.20%	4.90%	4.52%	5.36%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $13,402,000K ÷ $81,414,000K
= 16.46%

Abbott Laboratories' return on assets (ROA) has exhibited fluctuations over the period from March 31, 2020, to December 31, 2024. The ROA started at 5.36% in March 2020, decreased to 4.52% in June 2020, and then increased to 6.20% by December 2020. Subsequently, there was a continuous improvement in ROA, reaching its peak at 16.46% in December 2024, showing a strong performance. Overall, the trend indicates that Abbott Laboratories has been effectively utilizing its assets to generate profits, with a general upward trajectory in ROA over the analyzed period.